tiprankstipranks
Advertisement
Advertisement

RNAZ Stock Latest News

TransCode Sets Key Deadlines for 2026 Shareholder Meeting
Company AnnouncementsTransCode Sets Key Deadlines for 2026 Shareholder Meeting
2d ago
8K
RNAZ
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
PremiumThe Fly
Transcode Therapeutics initiates Phase 2a clinical trial with TTX-MC138
7d ago
RNAZ
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
PremiumCompany Announcements
TransCode Therapeutics Receives Nasdaq Listing Deficiency Notice
12d ago
8K
RNAZ
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 1.53M shares of common stock for holders
1M ago
RNAZ
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
PremiumThe Fly
Transcode Therapeutics files to sell 15.96M shares of common stock for holders
1M ago
RNAZ
Transcode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
PremiumThe FlyTranscode Therapeutics appoints Anna Moore as Chair of Scientific Advisory
1M ago
RNAZ
Transcode Therapeutics signs research agreement with Michigan State University
Premium
The Fly
Transcode Therapeutics signs research agreement with Michigan State University
1M ago
RNAZ
Transcode Therapeutics signs flexible financing agreement for up to $20M
Premium
The Fly
Transcode Therapeutics signs flexible financing agreement for up to $20M
2M ago
RNAZ
TransCode Therapeutics Secures New Financing to Extend Runway
PremiumCompany Announcements
TransCode Therapeutics Secures New Financing to Extend Runway
2M ago
8K
RNAZ
TransCode Therapeutics Delays 2025 Annual Filing
PremiumCompany Announcements
TransCode Therapeutics Delays 2025 Annual Filing
2M ago
RNAZ
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
PremiumCompany Announcements
TransCode Therapeutics Expands Pipeline With Oncolytic Virus Deal
3M ago
8K
RNAZ
Transcode Therapeutics enters exclusive license agreement with Unleash
PremiumThe Fly
Transcode Therapeutics enters exclusive license agreement with Unleash
3M ago
RNAZ
TransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
PremiumCompany AnnouncementsTransCode Unveils Tumor-Selective RIG-I Agonist Imaging Strategy
3M ago
8K
RNAZ
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
Premium
Company Announcements
TransCode Therapeutics Advances Phase 2a Colorectal Cancer Trial
4M ago
8K
RNAZ
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
Premium
The Fly
Transcode Therapeutics, Quantum Leap submit IND for Phase 2a trial of TTX-MC138
4M ago
RNAZ
TransCode Therapeutics reports promising preclinical glioblastoma results
PremiumCompany Announcements
TransCode Therapeutics reports promising preclinical glioblastoma results
5M ago
8K
RNAZ
Transcode Therapeutics announces publication of data supporting TTX-MC138
PremiumThe Fly
Transcode Therapeutics announces publication of data supporting TTX-MC138
5M ago
RNAZ
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
PremiumCompany Announcements
TransCode Therapeutics Strengthens Board with Veteran Financial Expert
5M ago
8K
RNAZ
TransCode Announces Collaboration for Phase 2a Trial
PremiumCompany Announcements
TransCode Announces Collaboration for Phase 2a Trial
6M ago
8K
RNAZ
Transcode, Quantum Leap announce new collaboration to study TTX-MC138
PremiumThe FlyTranscode, Quantum Leap announce new collaboration to study TTX-MC138
6M ago
RNAZ
TransCode Therapeutics Amends Preferred Stock Designation
Premium
Company Announcements
TransCode Therapeutics Amends Preferred Stock Designation
7M ago
8K
RNAZ
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
Premium
Company Announcements
TransCode Therapeutics Completes Phase 1a Trial for TTX-MC138
8M ago
8K
RNAZ

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >